These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 2448813

  • 1. Increasing fetal hemoglobin production in sickle cell disease: results of clinical trials.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1987; 251():455-66. PubMed ID: 2448813
    [Abstract] [Full Text] [Related]

  • 2. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP.
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic manipulation of fetal hemoglobin synthesis.
    Dover GJ, Humphries RK, Young N, Ley T, Boyer S, Charache S, Nienhuis A.
    Prog Clin Biol Res; 1985 Jun; 191():447-54. PubMed ID: 2413480
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fetal hemoglobin, sickling, and sickle cell disease.
    Charache S.
    Adv Pediatr; 1990 Jun; 37():1-31. PubMed ID: 1702260
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Determinants of fetal hemoglobin response to hydroxyurea.
    Steinberg MH.
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):8-14. PubMed ID: 9317196
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ, Charache S, Boyer SH.
    Trans Assoc Am Physicians; 1984 Jul; 97():140-5. PubMed ID: 6085527
    [No Abstract] [Full Text] [Related]

  • 12. [Hydroxyurea and other agents stimulating synthesis of fetal hemoglobin].
    de Montalembert M.
    Pathol Biol (Paris); 1999 Jan; 47(1):55-8. PubMed ID: 10081780
    [Abstract] [Full Text] [Related]

  • 13. Therapies to increase fetal hemoglobin in sickle cell disease.
    Steinberg MH.
    Curr Hematol Rep; 2003 Mar; 2(2):95-101. PubMed ID: 12901139
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R, Veith R, Papayannopoulou T, Stamatoyannopoulos G.
    Prog Clin Biol Res; 1985 Mar; 191():433-45. PubMed ID: 2413479
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Production of erythrocytes that contain fetal hemoglobin in anemia. Transient in vivo changes.
    Dover GJ, Boyer SH, Zinkham WH.
    J Clin Invest; 1979 Feb; 63(2):173-6. PubMed ID: 429549
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.